CreditReports.dk
HomeScreen companies

Muna Therapeutics ApS Financials, key figures and credit report

CVR number: 41142871 Established 2020 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Nordre Fasanvej 215, 2000 Frederiksberg
Gross profit -60 636.0 kDKK FY 2025 +51.4% vs 2024
EBIT -94 615.0 kDKK FY 2025 +42.2% vs 2024
Net debt -35 636.0 kDKK FY 2025 -867.6% vs 2024
Quick ratio 1.5 FY 2025 -1.3 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-49 692.75-98 234.04- 110 624.44- 124 746.00-60 636.00
Employee benefit expenses-8 756.25-20 425.84-25 334.09-28 780.00-29 340.00
Other operating expenses- 125.00
Total depreciation-3 020.09-3 790.15-6 558.99-10 073.00-4 639.00
EBIT-61 469.09- 122 450.03- 142 517.52- 163 724.00-94 615.00
Other financial income177.75301.442 265.744 205.005 534.00
Other financial expenses- 385.05- 585.72- 561.67-10 299.00-42 114.00
Net income from associates (fin.)-4 706.41-10 448.03-4 937.26
Pre-tax profit-66 382.79- 133 182.35- 145 750.71- 169 818.00- 131 195.00
Income taxes4 864.535 500.005 430.74-5 013.005 500.00
Net earnings-61 518.26- 127 682.35- 140 319.97- 174 831.00- 125 695.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights13 066.5817 417.5912 060.193 236.001 079.00
Intangible assets total13 066.5817 417.5912 060.193 236.001 079.00
Buildings100.8980.37419.00322.00
Machinery and equipment1 357.643 117.933 825.542 812.001 751.00
Other tangible assets3 611.00
Tangible assets total1 357.643 218.823 905.913 231.005 684.00
Holdings in group member companies53 692.2843 274.4138 306.6527 000.0027 000.00
Investments total53 737.8143 743.4339 331.3928 420.0028 427.00
Long term receivables total
Inventories total
Current amounts owed by group member comp.3 899.003 935.00
Prepayments and accrued income731.882 379.392 029.95931.0013 648.00
Current other receivables1 292.572 506.992 340.1715 322.002 653.00
Current deferred tax assets5 344.829 981.655 500.005 500.00
Short term receivables total7 369.2714 868.039 870.1220 152.0025 736.00
Cash and bank deposits108 532.38168 269.81103 042.87113 499.00250 198.00
Cash and cash equivalents108 532.38168 269.81103 042.87113 499.00250 198.00
Balance sheet total (assets)184 063.68247 517.68168 210.49168 538.00311 124.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital675.981 061.871 201.801 342.001 343.00
Other reserves6.67
Retained earnings223 155.27328 658.76266 078.03179 575.004 014.00
Profit of the financial year-61 518.26- 127 682.35- 140 319.97- 174 831.00- 125 695.00
Shareholders equity total162 312.99202 044.95126 959.866 086.00- 120 338.00
Provisions23.49140.00
Non-current loans from credit institutions91 246.00198 690.00
Non-current advances received3 686.00
Non-current other liabilities15.7522 971.0047 399.00
Non-current liabilities total15.75114 217.00249 775.00
Current trade creditors11 755.7713 491.9118 118.7216 715.0014 761.00
Current owed to group member7 532.8716 600.9812 036.4518 570.0015 872.00
Short-term deferred tax liabilities5 013.00
Other non-interest bearing current liabilities2 462.053 488.915 184.425 197.006 279.00
Accruals and deferred income11 851.695 911.052 740.00144 635.00
Current liabilities total21 750.7045 433.4941 250.6348 235.00181 547.00
Balance sheet total (liabilities)184 063.68247 517.68168 210.49168 538.00311 124.00
Page generated